ORANGE COUNTY
- Share via
From Times Staff and Wire Reports
InVitro Reports $5.1-Million Annual Loss: InVitro International, the Irvine developer of product toxicity tests, reported a loss of $5.1 million, or $1 a share, on revenue of $1.4 million for the fiscal year ended Sept. 30, 1992. That contrasted with a loss of $3.5 million, or 88 cents a share, based on sales of $530,183 for the transition period of seven months ended Sept. 30, 1991 (the company changed its fiscal year-end to Sept. 30 from Feb. 28).
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
